Ligand validation:6D8B

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6D8B designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6D8B_NAG_B_301	25%	69%	0.219	0.852	0.46	0.71	-	1	0	0	100%	0.9333
6D8B_NAG_E_401	20%	18%	0.219	0.819	0.97	2.51	1	6	8	0	100%	0.9333
6D8B_NAG_F_301	20%	75%	0.184	0.782	0.38	0.6	-	-	0	0	100%	0.9333
6D8B_NAG_D_301	6%	72%	0.362	0.797	0.43	0.64	-	1	0	0	100%	0.9333
6D8B_NAG_C_401	4%	61%	0.327	0.72	0.29	1.18	-	3	0	0	100%	0.9333
6D8B_NAG_A_401	1%	10%	0.357	0.434	1.95	2.41	2	3	0	0	100%	0.9333
6D8D_NAG_D_301	43%	8%	0.174	0.898	1.62	3.01	3	9	0	0	100%	0.9333
6D7C_NAG_J_301	34%	14%	0.19	0.871	1.57	2.3	3	7	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.